128 related articles for article (PubMed ID: 16393339)
1. Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Hank NC; Shapiro JR; Scheck AC
BMC Cancer; 2006 Jan; 6():2. PubMed ID: 16393339
[TBL] [Abstract][Full Text] [Related]
2. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
[TBL] [Abstract][Full Text] [Related]
3. Chromosome number and carmustine sensitivity in human gliomas.
Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
[TBL] [Abstract][Full Text] [Related]
4. BCNU-resistant human glioma cells with over-representation of chromosomes 7 and 22 demonstrate increased copy number and expression of platelet-derived growth factor genes.
Scheck AC; Mehta BM; Beikman MK; Shapiro JR
Genes Chromosomes Cancer; 1993 Nov; 8(3):137-48. PubMed ID: 7509621
[TBL] [Abstract][Full Text] [Related]
5. BCNU-sensitivity in parental cells and clones from four freshly resected near-diploid human gliomas: an astrocytoma, an anaplastic astrocytoma and two glioblastomas multiforme.
Shapiro JR; Ebrahim SA; Mohamed AN; Pu PY; Shapiro WR
J Neurooncol; 1993 Mar; 15(3):209-27. PubMed ID: 8395568
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression.
Bandres E; Andion E; Escalada A; Honorato B; Catalan V; Cubedo E; Cordeu L; Garcia F; Zarate R; Zabalegui N; Garcia-Foncillas J
J Neurooncol; 2005 Jul; 73(3):189-98. PubMed ID: 15980968
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells.
Zheng LT; Lee S; Yin GN; Mori K; Suk K
J Neurochem; 2009 Dec; 111(5):1238-51. PubMed ID: 19860839
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling.
Rhee CH; Ruan S; Chen S; Chenchik A; Levin VA; Yung AW; Fuller GN; Zhang W
Oncol Rep; 1999; 6(2):393-401. PubMed ID: 10023010
[TBL] [Abstract][Full Text] [Related]
9. MiR-21 enhanced glioma cells resistance to carmustine via decreasing Spry2 expression.
Wang GB; Liu JH; Hu J; Xue K
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5065-5071. PubMed ID: 29228450
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.
Ruan S; Okcu MF; Ren JP; Chiao P; Andreeff M; Levin V; Zhang W
Cancer Res; 1998 Apr; 58(7):1538-43. PubMed ID: 9537261
[TBL] [Abstract][Full Text] [Related]
11. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner.
Chakravarti A; Chakladar A; Delaney MA; Latham DE; Loeffler JS
Cancer Res; 2002 Aug; 62(15):4307-15. PubMed ID: 12154034
[TBL] [Abstract][Full Text] [Related]
12. Identification of transforming growth factor-beta1-binding protein overexpression in carmustine-resistant glioma cells by MRNA differential display.
Norman SA; Rhodes SN; Treasurywala S; Hoelzinger DB; Rankin Shapiro J; Scheck AC
Cancer; 2000 Aug; 89(4):850-62. PubMed ID: 10951349
[TBL] [Abstract][Full Text] [Related]
13. Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress.
Poschmann G; Grzendowski M; Stefanski A; Bruns E; Meyer HE; Stühler K
Biochim Biophys Acta; 2015 Jun; 1854(6):624-31. PubMed ID: 25484280
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Xu GW; Nutt CL; Zlatescu MC; Keeney M; Chin-Yee I; Cairncross JG
Cancer Res; 2001 May; 61(10):4155-9. PubMed ID: 11358839
[TBL] [Abstract][Full Text] [Related]
16. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
Yang DI; Chen SD; Yang YT; Ju TC; Xu JM; Hsu CY
Br J Pharmacol; 2004 Mar; 141(6):988-96. PubMed ID: 14980978
[TBL] [Abstract][Full Text] [Related]
17. Identification of a 116 kDa protein able to bind 1,3-bis(2-chloroethyl)-1-nitrosourea-damaged DNA as poly(ADP-ribose) polymerase.
Malapetsa A; Noë AJ; Poirier GG; Desnoyers S; Berger NA; Panasci LC
Mutat Res; 1996 Jan; 362(1):41-50. PubMed ID: 8538647
[TBL] [Abstract][Full Text] [Related]
18. The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.
Ngo TT; Peng T; Liang XJ; Akeju O; Pastorino S; Zhang W; Kotliarov Y; Zenklusen JC; Fine HA; Maric D; Wen PY; De Girolami U; Black PM; Wu WW; Shen RF; Jeffries NO; Kang DW; Park JK
J Natl Cancer Inst; 2007 Apr; 99(8):639-52. PubMed ID: 17440165
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells.
Yan YR; Xie Q; Li F; Zhang Y; Ma JW; Xie SM; Li HY; Zhong XY
Neuropathology; 2014 Apr; 34(2):128-34. PubMed ID: 24112388
[TBL] [Abstract][Full Text] [Related]
20. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
